Most clinical trial sites are utterly unprepared in the face of a
natural disaster and are paying a heavy price if they are unlucky
enough to be affected, delegates heard at last week's Drug
Information Association (DIA) conference...
Insurance firm Darwin is targeting the booming contract research
organisation (CRO) market by launching its own insurance cover
designed specifically for companies or organisations involved in
Japan is getting serious about clinical trial reform after years of
lagging behind the rest of the developed world in the availability
of drugs in the country, which ironically is the world's number two
pharma market behind the...
The European Medicines Agency (EMEA) makes sensible recommendations
in its recently released 'first-in-man' clinical trials guideline
but is somewhat passing the buck, according to a statistician with
expertise in clinical...
The pan-European drug regulator, the European Medicines Agency
(EMEA), has adopted a draft guideline for first-in-man clinical
studies for potential high-risk drugs in a bid to prevent a repeat
of last year's TGN1412 drug trial...